Meeting
2019 ASCO Annual Meeting
Study of tumor infiltrating immune CELLS and vasculature in human gliomas: Differences in IDH1/2 mutant versus IDH1/2WT tumors.
Authors
Maria Cruz Martin Soberón
Hospital Universitario 12 de Octubre, Madrid, Spain
Maria Cruz Martin Soberón , Juan Manuel Manuel Sepulveda Sanchez , Ricardo Gargini , Berta Segura , Jacquelin Gutierrez , Yolanda Ruano , Diana Cantero , Aurelio Hernandez-Lain , Pilar Sanchez-Gomez , Angel Perez-Núñez , Luis Jimenez Roldan , Patricia Marín , Daniel E. Castellano , Guillermo De Velasco , Teresa Cejalvo Jr.
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 37, 2019 (suppl; abstr 2030)
DOI
10.1200/JCO.2019.37.15_suppl.2030
Abstract #
2030
Poster Bd #
219
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Molecular features of gliomas with high tumor mutational burden.
First Author: Joanne Xiu
Poster
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Isolation and characterization of exosomes from IDH mutant gliomas.
First Author: Nils Ludwig
Poster
2023 ASCO Annual Meeting
Vulnerability to immune therapy in BRAF- and MYB-altered pediatric gliomas.
First Author: Michael DeCuypere
Poster
2023 ASCO Annual Meeting
New ESMO scale for clinical actionability of molecular targets (ESCAT) for gliomas based on a multicentric real world data cohort using next-generation sequencing (NGS).
First Author: Oriol Mirallas